WebDisclosure WebDisclosure
Basculer en Français
10885 Companies
236936 Keywords
165832 Articles
127156 Press releases
Headlines Articles Press releases Askeladden Capital Management LLC Remove
  1. Home
  2. Companies
  3. Askeladden Capital Management LLC
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/16/2025 at 20:03, 1 year 4 months ago

    Askeladden Capital Pushes for Change at AstroNova

    Financial Performance Board Changes AstroNova Askeladden Capital Q4 2025
  • BRIEF

    published on 04/16/2025 at 20:03, 1 year 4 months ago

    Askeladden Capital fait pression pour le changement chez AstroNova

    Performance Financière Changements Au Sein Du Conseil D'administration AstroNova Askeladden Capital T4 2025
  • PRESS RELEASE

    published on 04/16/2025 at 19:58, 1 year 4 months ago

    Askeladden Capital Comments on AstroNova Q4 and FY2025 Results

    AstroNova faces fourth consecutive quarter of poor performance, blames delays and covenant breach. Askeladden Capital nominates new directors to restore shareholder value
    Delays AstroNova Askeladden Capital Poor Performance Covenant Breach
    Logo of Askeladden Capital Management LLC
Previous page
1 2 3
Accesswire
  • Published on 08/27/2026 at 00:05, 29 minutes ago

    Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)

  • Published on 08/26/2026 at 23:00, 1 hour 34 minutes ago

    Datametrex Announces Transition to Semi-Annual Financial Reporting

  • Published on 08/26/2026 at 22:30, 2 hours 4 minutes ago

    AI/ML Innovations Inc. Closes First Tranche of Private Placement

  • Published on 08/26/2026 at 22:30, 2 hours 4 minutes ago

    Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement

  • Published on 08/26/2026 at 21:15, 3 hours 19 minutes ago

    Announces Private Placement of Convertible Promissory Notes

View all ACCESSWIRE
EQS Group
  • Published on 08/26/2026 at 23:05, 1 hour 28 minutes ago

    Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

  • Published on 08/26/2026 at 18:44, 5 hours 49 minutes ago

    AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results

  • Published on 08/26/2026 at 18:40, 5 hours 53 minutes ago

    MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM

  • Published on 08/26/2026 at 18:30, 6 hours 4 minutes ago

    Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China

  • Published on 08/26/2026 at 18:00, 6 hours 34 minutes ago

    MHM Corporate: reduces the nominal value of its shares to €0.011

View all EQS
Les Echos
  • Published on 08/26/2026 at 18:02, 6 hours 32 minutes ago

    Altareit: Altarea press release regarding the Primonial matter

  • Published on 08/26/2026 at 18:02, 6 hours 32 minutes ago

    Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial

  • Published on 08/26/2026 at 18:00, 6 hours 34 minutes ago

    Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)

  • Published on 08/26/2026 at 18:00, 6 hours 34 minutes ago

    Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)

  • Published on 08/26/2026 at 18:00, 6 hours 34 minutes ago

    KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy